Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human ST3GAL1 Antikörper:
anti-Mouse (Murine) ST3GAL1 Antikörper:
anti-Rat (Rattus) ST3GAL1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal ST3GAL1 Primary Antibody für WB - ABIN520192
Petrosyan, Cheng: Golgi fragmentation induced by heat shock or inhibition of heat shock proteins is mediated by non-muscle myosin IIA via its interaction with glycosyltransferases. in Cell stress & chaperones 2014
Show all 3 Pubmed References
ST3Gal I and ST6Gal I (zeige ST6GAL1 Antikörper) have different sialic acid donor specificity.
Describe differential expression profiles of alpha-2, 3-sialyltransferases (ST) and miR-4701-5p in three pairs of chronic myeloid leukemia (CML) cell lines and 48 clinical samples of bone marrow mononuclear cells from CML patients. miR-4701-5p directly targeted ST3GAL1 to reduce CML cells resistance to multiple chemotherapeutics in vitro.
rs113350588 and rs1048479 may alter the function of ST3GAL1. The GC haplotype was associated with an increased risk of death in subjects with influenza. The AT haplotype was associated with an increased risk of severe disease and death.
ST3GAL1-associated transcriptomic program portends poor prognosis in glioma patients with higher tumor grades.ST3Gal1-regulated self-renewal traits are crucial to the sustenance of glioblastoma multiforme growth.
Results show that ST3Gal1 uses GM130 (zeige GOLGA2 Antikörper)-GRASP65 (zeige GORASP1 Antikörper) and giantin (zeige GOLGB1 Antikörper), whereas C2GnT-L (zeige GCNT1 Antikörper) uses only giantin (zeige GOLGB1 Antikörper) for Golgi targeting and defective giantin (zeige GOLGB1 Antikörper) dimerization in PC-3 (zeige PCSK1 Antikörper) and DU145 prostate cancer cells causes fragmentation of the Golgi and prevents its targeting.
NMIIA is the master regulator of Golgi fragmentation induced by heat shock or inhibition/depletion of HSP70 (zeige HSP70 Antikörper)/90 through interaction with gylosyltransferases.
the high expression of ST3Gal I and ST6Gal I (zeige ST6GAL1 Antikörper), in skin tumors, is associated with tumors with greater potential for invasion and metastasis, as in the case of squamous cell carcinoma, and this may be related to their behavior.
Induction of COX-2 (zeige COX2 Antikörper) in breast cancer cell line results in the increased expression of ST3Gal-I.
Down-regulation of ST3GalI is correlated with breast cancer
Over-expression of ST3Gal-I promotes mammary tumorigenesis.
these results identified the core promoter region in the pST3Gal I promoter and demonstrated that Smad-3 (zeige SMAD3 Antikörper) binding to the Samd-3 binding site at -1020 is essential for transcriptional activation of pST3Gal I in TGF-beta1 (zeige TGFB1 Antikörper)-induced PK-15 cells.
ST3GAL-1 is an independent adverse prognostic factor for recurrence and survival of patients with clear cell renal cell carcinoma (zeige MOK Antikörper)
tryptophan and cysteine residues conserved in ST3Gal I are critical for its activity
ST3Gal-I mRNA is extensively expressed during Th2, but not Th1 (zeige HAND1 Antikörper) differentiation; suggests that lack of ST3Gal-I expression in Th1 (zeige HAND1 Antikörper) cells allows the formation of surface core2 O-glycans and supports their interactions with endothelial selectins
STsGal-I deficiency shows no discernible effect on the pattern of CD8 (zeige CD8A Antikörper) noncognate binding during thymocyte development and does not impact susceptibility of thymocytes to CD8 (zeige CD8A Antikörper)-induced apoptosis.
St3gal-1 functions to protect CD8 (zeige CD8A Antikörper) T cells from apoptosis
The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The encoded protein is normally found in the Golgi but can be proteolytically processed to a soluble form. Correct glycosylation of the encoded protein may be critical to its sialyltransferase activity. This protein, which is a member of glycosyltransferase family 29, can use the same acceptor substrates as does sialyltransferase 4B. Two transcript variants encoding the same protein have been found for this gene. Other transcript variants may exist, but have not been fully characterized yet.
, CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1
, ST3Gal I
, alpha 2,3-ST 1
, beta-galactoside alpha-2,3-sialyltransferase 1
, sialyltransferase 4A
, sialyltransferase 4A (beta-galactosidase alpha-2,3-sialytransferase)
, sialyltransferase 4A (beta-galactoside alpha-2,3-sialyltransferase)
, sialyltransferase 4A (beta-galactoside alpha-2,3-sialytransferase)
, gal beta-1,3 GalNAc alpha-2,3 sialyltransferase
, CMP-N-acetylneuraminate: [beta-galactosidase alpha-2,3] sialytransferase
, Gal beta1,3 GalNAc alpha2,3 sialyltransferase
, ST3GAL-I sialyltransferase
, sialyltransferase ST3Gal-I